6-diamidino-2-phenylindole Area postrema syndrome Enzyme-linked immunosorbent assays Amino acid Prognosis GSK-3β Disease modifying treatments Treatment response Myelin oligodendrocyte glycoprotein Disease-modifying treatments Immunohistochemical Cancer immunotherapy Bright Relapses IQR CRMP5 Blood brain barrier IBMs CD14 B cells DAPI Blood brain barrier T follicular regulatory cells Estradiol BBB Autoimmune diseases AKRB Biobank Neuromyelitis optica Interquartile range VEGF Neuromyelitis optica spectrum disorder Aquaporin-4 antibody Hippocampus Collapsing response mediator protein Post-partum Glutamate Central nervous system Neuromyelitis optica spectrum disorder T follicular helper cells T follicular regulatory cells B cells rituximab Cerebrospinal fluid BBB T follicular helper cells Immunohistochemical AKRB BSA-supplemented Kreps Ringer buffer Animal model ERRα Demyelination Anti-GFAP encephalomyelitis GABA Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Autoimmune encephalitis Circadian clock Adult neurogenesis Children Multiple sclerosis NMOSD Aquaporin-4 Adverse events Cilia Myelitis MOG antibodies Connexins Drosophila Aquaporin-4-IgG AQP4-IgG Astrocyte Interquartile range CSF Breastfeeding Blood-brain barrier Immunosuppressant Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation Bone Glia COVID-19 Cancer IBMs Database Clinically isolated syndrome CIS Optic neuritis CNS CP Neuroscience Autoantibodies CP Molecular biology Registry Ependymal cell Encephalitis IHC Biomarkers 6-diamidino-2-phenylindole IQR Neuroinflammation Neuromyelitis optica spectrum disorders Cerebrospinal fluid Immune checkpoint inhibitors Rituximab BSA-supplemented Kreps Ringer buffer Enzyme-linked immunosorbent assays DAPI Aquaporin-4 antibodies Pregnancy Central nervous system CSF Reproductive assistance Cannabinoid receptor type 2 Antivascular endothelial growth factor Endocannabinoid system